Uniwarfin, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Pulmonary Embolism, Deep Vein Thrombosis, Blood Clotting Disorders. Other than this, Uniwarfin has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Uniwarfin. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Uniwarfin can also lead to other problems, which have been listed below. Usually, these side effects of Uniwarfin go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Uniwarfin's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Uniwarfin related warnings talks about Uniwarfin's effects on the liver, heart and kidney.
Uniwarfin can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Uniwarfin in conditions like Bleeding, Diabetes, High Blood Pressure. Some other conditions that can be affected by Uniwarfin are listed in the contraindications section below.
Drug reaction of Uniwarfin with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Uniwarfin is considered safe while driving, and is addictive.
Uniwarfin is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Uniwarfin is used -
Severe
Moderate
Mild
Is the use of Uniwarfin safe for pregnant women?
Uniwarfin can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Uniwarfin right away. Take your doctor's advice before taking it again.
Is the use of Uniwarfin safe during breastfeeding?
Uniwarfin can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Uniwarfin on the Kidneys?
Very few cases of side effects of Uniwarfin on kidney have been reported.
What is the effect of Uniwarfin on the Liver?
Uniwarfin is rarely harmful for the liver.
What is the effect of Uniwarfin on the Heart?
Use of Uniwarfin may be dangerous for the heart. Do not use it without doctor's advice.
Uniwarfin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Uniwarfin unless your doctor advises you to do so -
Is this Uniwarfin habit forming or addictive?
Forming a habit of Uniwarfin has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Uniwarfin since it does not cause drowsiness.
Is it safe?
Uniwarfin is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Uniwarfin is unable to treat or cure mental disorders.
Interaction between Food and Uniwarfin
Information is not available on the interaction of any foods with Uniwarfin, due to a lack of research on this.
Interaction between Alcohol and Uniwarfin
Information about the interaction of Uniwarfin and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1283-1284
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 620-622
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coumadin (warfarin sodium)